Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yangjun Cai

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Chemical Communications (Cambridge, England)|February 9, 2005
NaI-catalyzed highly regioselective ring-opening [1 + 2] cycloaddition reaction of cyclopropenes with imines: highly stereoselective synthesis of cis-vinylic aziridinesShengming Ma, Junliang Zhang, Lianghua Lu, et al.
Biochemical and Biophysical Research Communications|March 19, 2023
Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling PathwayMingyao Yang, Shifen Huang, Yelu Zhao, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 13, 2023
The construction and analysis of a prognostic assessment model based on P53-related multi-genes in breast carcinomaYangjun Cai, Linyi Wang, Wangjin Xu, et al.
Breast Cancer Research and Treatment|April 9, 2025
A potential therapeutic molecule target: lncRNA AK023507 inhibits the metastasis of breast cancer by regulating the WNT/DOCK4/β-catenin axisBiyu Diao, Yangjun Cai, Dandan Song, et al.
Pharmacology|May 14, 2024
M6A RNA Methylation-Mediated Dysregulation of AGAP2-AS1 Promotes Trastuzumab Resistance of Breast CancerYangjun Cai, Haihong Zheng, Dong Xu, et al.
ACS Nano|July 14, 2017
Oblique Colloidal Lithography for the Fabrication of Nonconcentric FeaturesZhi Zhao, Yang Cao, Yangjun Cai, et al.
BMC Cancer|July 11, 2021
Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast CancerDandan Song, Yingying Hu, Biyu Diao, et al.
Cancer Management and Research|October 29, 2020
Long Non-Coding RNA NLIPMT as a Tumor Suppressor and Inhibitor of Cell Proliferation and Metastasis in Papillary Thyroid CarcinomaFen Zhang, Yangjun Cai, Biyu Diao, et al.
Journal of Cellular Physiology|November 13, 2018
Overexpression of novel lncRNA NLIPMT inhibits metastasis by reducing phosphorylated glycogen synthase kinase 3β in breast cancerYang Jiang, Lili Lin, Shen Zhong, et al.
BMC Cancer|May 20, 2026
Real-world outcomes of CDK4/6 inhibitors in combination with endocrine therapy as first-line treatment for HR-positive/HER2-negative advanced breast cancer: multicenter evidence from ChinaXianan Guo, Panni Li, Shiyao Hu, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Chemical Communications (Cambridge, England)|February 9, 2005
NaI-catalyzed highly regioselective ring-opening [1 + 2] cycloaddition reaction of cyclopropenes with imines: highly stereoselective synthesis of cis-vinylic aziridinesShengming Ma, Junliang Zhang, Lianghua Lu, et al.
Biochemical and Biophysical Research Communications|March 19, 2023
Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling PathwayMingyao Yang, Shifen Huang, Yelu Zhao, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 13, 2023
The construction and analysis of a prognostic assessment model based on P53-related multi-genes in breast carcinomaYangjun Cai, Linyi Wang, Wangjin Xu, et al.
Breast Cancer Research and Treatment|April 9, 2025
A potential therapeutic molecule target: lncRNA AK023507 inhibits the metastasis of breast cancer by regulating the WNT/DOCK4/β-catenin axisBiyu Diao, Yangjun Cai, Dandan Song, et al.
Pharmacology|May 14, 2024
M6A RNA Methylation-Mediated Dysregulation of AGAP2-AS1 Promotes Trastuzumab Resistance of Breast CancerYangjun Cai, Haihong Zheng, Dong Xu, et al.
ACS Nano|July 14, 2017
Oblique Colloidal Lithography for the Fabrication of Nonconcentric FeaturesZhi Zhao, Yang Cao, Yangjun Cai, et al.
BMC Cancer|July 11, 2021
Effects of Tamoxifen vs. Toremifene on fatty liver development and lipid profiles in breast CancerDandan Song, Yingying Hu, Biyu Diao, et al.
Cancer Management and Research|October 29, 2020
Long Non-Coding RNA NLIPMT as a Tumor Suppressor and Inhibitor of Cell Proliferation and Metastasis in Papillary Thyroid CarcinomaFen Zhang, Yangjun Cai, Biyu Diao, et al.
Journal of Cellular Physiology|November 13, 2018
Overexpression of novel lncRNA NLIPMT inhibits metastasis by reducing phosphorylated glycogen synthase kinase 3β in breast cancerYang Jiang, Lili Lin, Shen Zhong, et al.
BMC Cancer|May 20, 2026
Real-world outcomes of CDK4/6 inhibitors in combination with endocrine therapy as first-line treatment for HR-positive/HER2-negative advanced breast cancer: multicenter evidence from ChinaXianan Guo, Panni Li, Shiyao Hu, et al.
Pageof 3